Sai Smaran Mekala

 Optimized laser-cutting processes for coronary stent frameworks, improving dimensional accuracy by 14% and ensuring structural integrity for high-risk cardiovascular implants.  Developed surface finishing and passivation controls for nitinol-based guidewires, reducing corrosion-related defects by 17% and enhancing long-term biocompatibility performance.  Introduced in-line optical inspection systems for balloon catheter assembly, detecting micro-defects in tubing and lowering post-production rework by 19% across multiple product lines.  Coordinated sterilization validation protocols (ETO and gamma methods) for implantable devices, cutting qualification cycle times by 12% while maintaining compliance with ISO 11135/11137 standards.  Partnered with R&D teams during design transfer of a next-gen transcatheter heart valve, accelerating production readiness by 22% and ensuring seamless scale-up from pilot to commercial manufacturing.

 Executed process validation for automated insulin pump assembly lines, reducing calibration errors by 17% and ensuring robust compliance with FDA 21 CFR Part 11 manufacturing standards.  Developed risk control framework using FMEA for Omnipod infusion set manufacturing, addressing 12 critical failure modes and improving device reliability, patient safety, and regulatory compliance.  Implemented real-time defect tracking system for adhesive bonding processes, decreasing lot rejection rate by 14% and improving long-term reliability of wearable drug-delivery components.  Coordinated supplier quality audits for polymeric materials, increasing first-pass acceptance by 19% and enhancing consistency of biocompatible plastics used in large-scale insulin infusion set production.  Facilitated cross-functional Kaizen workshops targeting packaging line bottlenecks, cutting changeover times by 22% and accelerating market delivery timelines for next-generation Omnipod wearable products.

 Implemented Good Manufacturing Practices (GMP) across nutraceutical production units, achieving 17% reduction in contamination incidents and strengthening compliance for ISO 22000 certification requirements.  Designed capacity planning strategies that balanced workforce utilization and machine uptime, increasing output by 19% while maintaining strict quality and regulatory standards for dietary supplement lines.  Directed supplier audits and risk assessments, improving raw material acceptance rate by 21% and ensuring sustained reliability of imported botanical extracts for large-scale immunology product manufacturing.  Spearheaded workflow optimization initiatives, reducing batch changeover times by 14%, ensuring faster delivery timelines while lowering operational bottlenecks in capsule and powder formulation facilities.  Established real-time SPC dashboarding for blending processes, providing predictive alerts that minimized deviations and decreased batch rejection rate by 11% in high-volume production runs.  Coordinated CAPA and root cause analysis on recurring equipment malfunctions, reducing downtime by 15% and extending lifecycle of encapsulation machinery across multiple production shifts.  Facilitated cross-functional Kaizen events targeting packaging efficiency, enhancing throughput by 22% while reducing material waste in blister and bottle packaging lines for immunology products.  Oversaw regulatory audits for HACCP and FSSAI compliance, ensuring full adherence and enabling company expansion into two new international healthcare markets through strengthened quality certifications.

 Executed process validation (IQ/OQ/PQ) for high-voltage switchgear assembly, enhancing compliance and reducing equipment downtime by 18%, ensuring smooth transition from prototype to mass production.  Coordinated cross-functional teams for CAPA implementation, resolving non-conformances within 11 days, improving supplier compliance and strengthening component reliability for critical power distribution projects.  Optimized workflow using Lean and 5S principles, increasing assembly line efficiency by 16% and minimizing material handling delays across multiple production batches.  Conducted DOE and root cause analysis on metallurgical failures, improving welding consistency by 21%, ensuring robustness of joints in transformer component manufacturing processes.  Facilitated supplier quality management initiatives, introducing gage R&R studies that reduced measurement variation by 12%, ensuring precision in dimensional checks of imported steel laminations.

 Spearheaded an in-depth research initiative focusing on the rigorous evaluation of the creep properties of INCOLOY 800HT furnace tubes within the Vinyl Chloride Monomer plant, collaborating seamlessly with senior engineers to conceptualize, design, and meticulously execute a series of experiments aimed at collecting and analyzing intricate data pivotal for the comprehensive assessment of tube performance and longevity.  Synthesized the results of the research endeavors into comprehensive and meticulously detailed research reports, effectively presenting findings and actionable recommendations to department leaders, thereby delivering invaluable insights that played a pivotal role in enhancing equipment reliability and overall operational efficiency.

Internship focussed on acquiring awareness of the steel plant and integration of processes

Conducted statistical research and Produced viable Hafnium based bulk metallic glasses